市場調查報告書
商品編碼
937379

治療類鴉片物質使用失調及藥物成癮所使用的醫療設備的全球市場:到2027年的展望

Global Medical Devices used for Opioid Use Disorder and Drug Addiction Treatment Market Outlook 2027

出版日期: | 出版商: Research Nester | 英文 30 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供類治療鴉片物質使用失調和藥物成癮所使用的醫療設備的全球市場調查,提供市場情況,各地區,各產品分析,數位療法,最新趨勢,企業簡介等資訊。

目錄

第1章 簡介

第2章 各產品的市場區隔(穿戴式設備和非穿戴式設備)

第3章 市場方案

第4章 全球市場的各地區分析

  • 北美
  • 歐洲
  • 亞太地區

第5章 全球市場的各產品分析(穿戴式及非穿戴式設備)

  • 北美
  • 歐洲
  • 亞太地區

第6章 全球數位療法市場

第7章 最新的新聞與趨勢

第8章 企業簡介

  • DyAnsys
  • Innovative Health Solutions INC
  • Spark Biomedical Inc.
  • Brainsway Ltd.
  • EvON Medics
  • Pear Therapeutics Inc.
目錄

COVID-19 update included

The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

There are certain medical devices that are used to treat opioid use disorder as well as drug addiction. These can be broadly classified into wearable devices and non-wearable devices. The highest demand for medical devices is observed by Drug Relief by DyAnsys and NSS-2 BRIDGE by Innovative Health Solutions, Inc. (HIS). They are both Class II medical devices with percutaneous electrical nerve field stimulator (PNFS) systems that reduce the symptoms of opioid withdrawal. The market for medical devices used for opioid use disorder and drug addiction treatment is projected to grow by a significant CAGR of 16.86% during the forecast period, i.e., 2020-2027. It is anticipated to reach a market value of USD 21.85 million by the end of 2027.

The market is segmented by product into wearable devices and non-wearable devices, out of which, the segment for wearable devices is anticipated to hold the leading share in the market as a result of increasing availability of wearable devices. The wearable devices segment is anticipated to attain a higher market size of USD 19.79 million by 2027. In addition to this, the high demand for wearable devices as they are easy to use is another factor contributing towards the large share of wearable devices segment in the market.

The medical devices used for opioid use disorder and drug addiction treatment market is segmented on the basis of region into North America, Europe, Asia Pacific, Latin America and Middle East and South Africa. On the basis of region, the market in North America is anticipated to hold the leading share along with the highest growth, which is predicted to be observed by the market in North America with a CAGR of 18.48% over the forecast period. This can be attributed to the presence of leading companies in the region as well as generation of maximum revenue from these medical devices in the United States.

Some of the key industry leaders in the global medical devices used for opioid use disorder and drug addiction treatment market are: DyAnsys Inc., Innovative Health Solutions Inc., SPARK BIOMEDICAL, INC, Brainsway, EvON Medics and Pear Therapeutics, Inc.

Table of Contents

Part 1 Introduction

Part 2 Market Segmentation By Product (Wearable & Non-Wearable Devices)

Part 3 Market Scenario of Medical Devices Used for Opioid Use Disorder & Drug Addiction

Part 4 Global Market Analysis, By Region

  • North America
  • Europe
  • Asia Pacific

Part 5 Global Market Analysis, By Product (Wearable & Non-Wearable Devices)

  • North America
  • Europe
  • Asia Pacific

Part 6 Global Digital Therapeutics Used for Opioid Use Disorder & Drug Addiction Treatment Market

Part 7 Recent News & Development

Part 8 Company Profiles

  • DyAnsys
  • Innovative Health Solutions INC
  • Spark Biomedical Inc.
  • Brainsway Ltd.
  • EvON Medics
  • Pear Therapeutics Inc.